Who
Thomas W. Burnell
CEO, President & Chairman
Company insider
Files Form 4 as: CEO, President & Chairman, Interpace Biosciences.
In numbers
- Trades disclosed
- 13
- Buys
- 1
- Sells
- 0
- Bought
- $94K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Dec 2020
- Last trade
- 20 Aug 2026
- Last filed
- 20 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Aug 2026filed 20 Aug 2026 | Interpace BiosciencesMedical Devices | SEC FORM 4 Code M | —1,966,763 at $0.00 | filing |
| 20 Aug 2026filed 20 Aug 2026 | Interpace BiosciencesMedical Devices | SEC FORM 4 Code F | $937K581,718 at $1.61 | filing |
| 20 Aug 2026filed 20 Aug 2026 | Interpace Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —1,966,763 at $0.00 | filing |
| 20 Aug 2026filed 20 Aug 2026 | Interpace Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —1,966,763 at $0.00 | filing |
| 20 Aug 2026filed 20 Aug 2026 | Interpace Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,966,763 at $0.00 | filing |
| 20 Aug 2026filed 20 Aug 2026 | Interpace Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —554,018 at $0.00 | filing |
| 20 Aug 2026filed 20 Aug 2026 | Interpace Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,966,763 at $0.00 | filing |
| 20 Aug 2026filed 20 Aug 2026 | Interpace Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —554,018 at $0.00 | filing |
| 20 Aug 2026filed 20 Aug 2026 | Interpace BiosciencesMedical Devices | SEC FORM 4 Code M | —1,966,763 at $0.00 | filing |
| 20 Aug 2026filed 20 Aug 2026 | Interpace BiosciencesMedical Devices | SEC FORM 4 Code F | $937K581,718 at $1.61 | filing |
| 21 May 2021filed 25 May 2021 | Interpace BiosciencesMedical Devices | SEC FORM 4 Bought | $94K10,855 at $8.68 | filing |
| 1 Dec 2020filed 2 Dec 2020 | Interpace BiosciencesMedical Devices | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 1 Dec 2020filed 2 Dec 2020 | Interpace BiosciencesMedical Devices | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.